Skip to content

Gonadal Steroid Manipulation and Personality Characteristics: Association With Mood Fluctuations and in Vitro Fertilization (IVF) Outcomes

Gonadal Steroid Manipulation and Personality Characteristics: Association With Mood Fluctuations & IVF Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01032421
Acronym
IVF
Enrollment
100
Registered
2009-12-15
Start date
2006-01-31
Completion date
2007-12-31
Last updated
2009-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mood Disorders

Keywords

women admitted to the In Vitro Fertilization unit

Brief summary

The current study's primary aim is to investigate the association between neuroendocrine fluctuations and mood disorders by monitoring mood states over distinct hormonal phases during in-vitro-fertilization (IVF) treatment. The secondary goal of this study is to explore psychological profiles and coping mechanisms of women undergoing IVF, and to identify the ones that are associated with successful psychological adaptation to the process and a successful biological outcome.

Interventions

PROCEDUREIVF procedure

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 42 Years
Healthy volunteers
Yes

Inclusion criteria

1. Admitted for their first or second IVF cycle; 2. Demonstrated sufficient communication skills and level of understanding in the Hebrew language; 3. signed an informed consent; 4. Were under the age of 42; 5. Were not suffering from endometriosis or male factor in patients who underwent testicular sperm extraction (TESE); 6. Were not under psychotherapeutic or psychopharmacological treatment. The accepted indications for the IVF included a female factor, male factor or unexplained infertility.

Exclusion criteria

1\. All others.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026